GEMIX
Price
$37.95
Change
+$0.04 (+0.11%)
Updated
Aug 26 closing price
Net Assets
3.31B
RNWBX
Price
$103.18
Change
+$0.23 (+0.22%)
Updated
Aug 27 closing price
Net Assets
88.6B
Interact to see
Advertisement

GEMIX vs RNWBX

GEMIX vs RNWBX Comparison Chart in %
View a ticker or compare two or three
VS
GEMIX vs. RNWBX commentary
Aug 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEMIX is a Hold and RNWBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 88.6B vs. GEMIX (3.31B). GEMIX pays higher dividends than RNWBX: GEMIX (0.65) vs RNWBX (0.42). GEMIX was incepted earlier than RNWBX: GEMIX (29 years) vs RNWBX (24 years). RNWBX (1.66) is less costly to investors than GEMIX (1.12). RNWBX is a more actively managed with annual turnover of: 46.00 vs. GEMIX (43.00). RNWBX has a lower initial minimum investment than GEMIX: RNWBX (250) vs GEMIX (1000000). GEMIX annual gain was more profitable for investors over the last year : 38.62 vs. RNWBX (20.02). GEMIX return over 5 years is better than : 27.11 vs. RNWBX (14.34).
GEMIXRNWBXGEMIX / RNWBX
Total Expense Ratio1.031.6662%
Annual Report Gross Expense Ratio1.121.6667%
Fund Existence29 years24 years-
Gain YTD24.37716.285150%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.31B88.6B4%
Annual Yield % from dividends0.650.42154%
Returns for 1 year38.6220.02193%
Returns for 3 years87.9849.97176%
Returns for 5 years27.1114.34189%
Returns for 10 years142.11100.25142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICPAX9.080.11
+1.23%
Integrity Mid-North American Resources A
AEIMX9.700.02
+0.21%
American Century Equity Income G
DDVAX13.100.01
+0.08%
Nomura Value A
SSCCX0.41N/A
N/A
Saratoga Small Capitalization C
TCMHX20.65N/A
N/A
Nuveen Quant Mid Cap Growth I